Clark Wealth Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Clark Wealth Partners's GSK Position: Q3 2026 in Review
Clark Wealth Partners increased its GSK (GSK) stake by 0.88% in Q3 2026, buying an estimated $204 and bringing the position to 460 shares worth $22.4K. The position accounts for 0.01% of the portfolio, ranked #180.
Clark Wealth Partners first reported a position in GSK in Q4 2024 and has held it in 8 quarters since. The position peaked at $25.2K in Q1 2026. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Clark Wealth Partners held 460 shares of GSK worth $22.4K as of Q3 2026.
- Clark Wealth Partners bought 4 GSK shares in Q3 2026, an estimated $204.
- GSK made up 0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #180 holding.
- Clark Wealth Partners first reported a position in GSK in Q4 2024 and has held it in 8 quarters since.
- Clark Wealth Partners's GSK position peaked at $25.2K in Q1 2026.
- 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.